| Protein arginine deiminase 4 (PAD4): Current understanding and future therapeutic potential. JE Jones, CP Causey, B Knuckley, JL Slack-Noyes, PR Thompson Current opinion in drug discovery & development 12 (5), 616, 2009 | 269 | 2009 |
| Protein arginine deiminase 4: a target for an epigenetic cancer therapy JL Slack, CP Causey, PR Thompson Cellular and Molecular Life Sciences 68 (4), 709-720, 2011 | 128 | 2011 |
| Synthesis and screening of a haloacetamidine containing library to identify PAD4 selective inhibitors JE Jones, JL Slack, P Fang, X Zhang, V Subramanian, CP Causey, ... ACS Chemical Biology 7 (1), 160-165, 2011 | 112 | 2011 |
| A fluopol-ABPP HTS assay to identify PAD inhibitors B Knuckley, JE Jones, DA Bachovchin, J Slack, CP Causey, SJ Brown, ... Chemical Communications 46 (38), 7175-7177, 2010 | 102 | 2010 |
| Correction to The Development of N-α-(2-Carboxyl) benzoyl-N 5-(2-fluoro-1-iminoethyl)-l-ornithine Amide (o-F-amidine) and N-α-(2-Carboxyl) benzoyl-N 5-(2-chloro-1-iminoethyl)-l … CP Causey, JE Jones, JL Slack, D Kamei, LE Jones Jr, V Subramanian, ... Journal of medicinal chemistry 54 (22), 7942-7942, 2011 | 92* | 2011 |
| The Development of N-α-(2-Carboxyl) benzoyl-N 5-(2-fluoro-1-iminoethyl)-l-ornithine Amide (o-F-amidine) and N-α-(2-Carboxyl) benzoyl-N 5-(2-chloro-1-iminoethyl)-l-ornithine … CP Causey, JE Jones, JL Slack, D Kamei, LE Jones Jr, V Subramanian, ... Journal of medicinal chemistry 54 (19), 6919-6935, 2011 | 92 | 2011 |
| Autodeimination of protein arginine deiminase 4 alters protein–protein interactions but not activity JL Slack, LE Jones Jr, MM Bhatia, PR Thompson Biochemistry 50 (19), 3997-4010, 2011 | 82 | 2011 |
| Blast-induced moderate neurotrauma (BINT) elicits early complement activation and tumor necrosis factor alpha (TNFα) release in a rat brain JJ Dalle Lucca, M Chavko, MA Dubick, S Adeeb, MJ Falabella, JL Slack, ... Journal of the neurological sciences 318 (1), 146-154, 2012 | 68 | 2012 |
| Development and use of clickable activity based protein profiling agents for protein arginine deiminase 4 JL Slack, CP Causey, Y Luo, PR Thompson ACS chemical biology 6 (5), 466-476, 2011 | 47 | 2011 |
| Decay-accelerating factor limits hemorrhage-instigated tissue injury and improves resuscitation clinical parameters JJ Dalle Lucca, Y Li, MO Simovic, JL Slack, A Cap, MJ Falabella, ... Journal of Surgical Research 179 (1), 153-167, 2013 | 31 | 2013 |
| Protective effects of decay-accelerating factor on blast-induced neurotrauma in rats Y Li, M Chavko, JL Slack, B Liu, RM McCarron, JD Ross, JJ Dalle Lucca Acta Neuropathologica Communications 1 (1), 52, 2013 | 28 | 2013 |
| COMPLEMENT INHIBITION AS THERAPEUTIC STRATEGY IN PORCINE TRAUMATIC HEMORRHAGE K Waldrep, J Slack, M Simovic, JD Lucca SHOCK 37, 98-98, 2012 | | 2012 |
| BLAST-INDUCED NEUROTRAUMA ELICITS EARLY COMPLEMENT ACTIVATION AND TNF ALPHA RELEASE IN RAT BRAIN J Slack, Y Li, JD Lucca SHOCK 37, 39-39, 2012 | | 2012 |
| Unlocking the PADlock: Elucidation of Protein Arginine Deiminase 4 Function, Activity and Activation Dynamics J Slack | | 2010 |
| The Effect of Human Recombinant Complement 1 Inhibitor on a Porcine Noncompressible Traumatic Hemorrhage Model J Dalle Lucca, M Simovic, J Slack, J Sondeen, M Valiyaveettil, M Dubick, ... | | |
